Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
eSense-Cancer: Feasibility and Usability of an Online Sex Therapy Program for Ovarian Cancer Survivors
EF 2022-23
Résumé
Sexual morbidities due to treatments for gynecological cancers affect close to 90% of survivors. Considering that one in 79 women will develop ovarian cancer in their lifetime and will most likely experience some form of sexual dysfunction, establishing proper survivorship care regarding sexual health is imperative. Moreover, with limited available resources and major barriers to accessing sex therapy, we believe that an online intervention such as eSense-Cancer could help survivors overcome these distressing sexual consequences. This study aims at establishing the feasibility and usability as well as the preliminary efficacy of a digital health intervention, eSense-Cancer, which delivers cognitive-behavioural and mindfulness-based therapy (CBT and MBT, respectively) to survivors of ovarian cancer who experience sexual problems following treatment for their cancer. For this study, 30 survivors will be recruited and randomized to either arm of the program (CBT or MBT). Dimensions of acceptability, implementation, practicality, and adaptation will be assessed as measures of feasibility and surveys assessing impressions of the different eSense modules will be used to evaluate usability. Effect sizes will also be analysed to determine the preliminary efficacy of the intervention. We hypothesize that eSense-Cancer will be well-received by the participants and show great feasibility and usability. Further, we believe that initial measures of clinical outcomes will demonstrate improvements in the sexual functioning of the participants. Finally, the preliminary results of this study could inform a future larger randomized control trial establishing the exact efficacy of eSense-Cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486547
Name
Allaire-Stacey Genevieve R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
eSense-Cancer: Feasibility and Usability of an Online Sex Therapy Program for Ovarian Cancer Survivors
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Accessibility; Cognitive-Behavioural Therapy; Digital Health; Interdisciplinary Care; Mental Health; Mindfulness; Ovarian Cancer; Sexual Dysfunction; Sexual Health; Survivorship Care
Abstract
Sexual morbidities due to treatments for gynecological cancers affect close to 90% of survivors. Considering that one in 79 women will develop ovarian cancer in their lifetime and will most likely experience some form of sexual dysfunction, establishing proper survivorship care regarding sexual health is imperative. Moreover, with limited available resources and major barriers to accessing sex therapy, we believe that an online intervention such as eSense-Cancer could help survivors overcome these distressing sexual consequences. This study aims at establishing the feasibility and usability as well as the preliminary efficacy of a digital health intervention, eSense-Cancer, which delivers cognitive-behavioural and mindfulness-based therapy (CBT and MBT, respectively) to survivors of ovarian cancer who experience sexual problems following treatment for their cancer. For this study, 30 survivors will be recruited and randomized to either arm of the program (CBT or MBT). Dimensions of acceptability, implementation, practicality, and adaptation will be assessed as measures of feasibility and surveys assessing impressions of the different eSense modules will be used to evaluate usability. Effect sizes will also be analysed to determine the preliminary efficacy of the intervention. We hypothesize that eSense-Cancer will be well-received by the participants and show great feasibility and usability. Further, we believe that initial measures of clinical outcomes will demonstrate improvements in the sexual functioning of the participants. Finally, the preliminary results of this study could inform a future larger randomized control trial establishing the exact efficacy of eSense-Cancer.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Allaire-Stacey, Genevieve R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~